Home/Recalls/FDA-D-0526-2026
FDA DrugsClass II

Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single ...

Published: May 6, 2026Recall ID: D-0526-2026Category: drugsCountry: US

Reason for Recall / Hazard

This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.

Product Description & Identification

Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bottles, Distr. by: Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922, NDC 0054-0282-59.

Additional Source Details

FieldValue
CityColumbus
StateOH
Openfda › Upc0300540282592
Openfda › Unii2UY4M2U3RA
Openfda › RouteORAL
Openfda › Rxcui904447
Openfda › Spl id56e063a8-8c3d-4445-91fd-0c8806c2b127
Openfda › Brand nameALENDRONATE SODIUM
Openfda › Spl set idc910bb05-279b-4ffa-a867-46f4a0853ed5
Openfda › Package ndc0054-0282-59
Openfda › Product ndc0054-0282
Openfda › Generic nameALENDRONATE SODIUM
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Substance nameALENDRONATE SODIUM
Openfda › Manufacturer nameHikma Pharmaceuticals USA Inc.
Openfda › Application numberANDA090520
Openfda › Is original packagertrue
Event id98744
Address 11809 Wilson Rd
Code infoLot # AC2040A, Exp Date: 04/2026
Postal code43228-9579
Report date20260506
Product typeDrugs
Product quantity4 single dose 75 ml bottles
Reason for recallThis recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260407
Initial firm notificationLetter
Center classification date20260508

Overview

  • Recalling FirmHikma Pharmaceuticals USA INC
  • StatusOngoing
  • Risk LevelClass II
  • DistributionUS Nationwide.
Official Agency Alert